GlassScriptPhysician profile
Julie A Fenner
NPI 1558537894
$946.18
in general payments reported to CMS, 2019-2025
13 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.44 · 2021: $153 · 2022: $199 · 2023: $201 · 2024: $159 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.41 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $256.41 | 2019-2024 | Taltz, Olumiant, Ebglyss |
| Abbvie INC. | $186.12 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $119.44 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $109.08 | 2023 | Sotyktu |
| Janssen Biotech, INC. | $99.73 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $31.65 | 2025 | |
| Leo Pharma INC. | $27.28 | 2025 | Anzupgo |
| Galderma Laboratories, L.P. | $24.26 | 2024 | Aklief |
| Dermavant Sciences, INC. | $23.49 | 2024 | Vtama |
| Pfizer INC. | $19.59 | 2025 | |
| Strata Skin Sciences, INC. | $19.14 | 2025 | Xtrac |
| Botanix Sb INC | $17.84 | 2025 | Sofdra |
| Ucb, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Fenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.